Barry Kevane
Mater Misericordiae University Hospital
54 Papers
74 Citations
Barry Kevane is an academic researcher from Mater Misericordiae University Hospital. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 10, co-authored 37 publications. Previous affiliations of Barry Kevane include Rotunda Hospital & University College Dublin.
Chat about Author
Papers
COVID-19 induces a hyperactive phenotype in circulating platelets.
Shane P. Comer,Sarah Cullivan,Paulina B. Szklanna,Luisa Weiss,Steven Cullen,Sarah Kelliher,Albert Smolenski,Claire A Murphy,Claire A Murphy,Haidar Altaie,John Curran,Katherine M.A. O'Reilly,Katherine M.A. O'Reilly,Aoife G. Cotter,Aoife G. Cotter,Brian Marsh,Brian Marsh,Sean Gaine,Sean Gaine,Patrick W. G. Mallon,Brian McCullagh,Brian McCullagh,Niamh Moran,Fionnuala Ní Áinle,Barry Kevane,Barry Kevane,Patricia B. Maguire +26 more
TL;DR: In this article, the authors assessed clinical platelet parameters and circulating platelet activity in patients with severe and non-severe Coronavirus Disease 2019 (COVID-19), caused by the novel SARS-CoV-2, and found that platelet reactivity may contribute to hypercoagulability.
Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management
TL;DR: A gulf exists between current recommendations and clinical practice; greater efforts are required to ensure effective implementation of strategies to reduce the incidence of vte in patients with cancer.
80
Anticoagulation Practice Patterns in COVID-19: A Global Survey.
Rachel P. Rosovsky,Kristen M. Sanfilippo,Tzu-Fei Wang,Sandeep K. Rajan,Surbhi Shah,Karlyn Martin,Fionnuala Ní Áinle,Menno V. Huisman,Beverley J. Hunt,Susan R. Kahn,Susan R. Kahn,Barry Kevane,Agnes Y.Y. Lee,Claire McLintock,Lisa Baumann Kreuziger +14 more
- 01 Aug 2020
TL;DR: Best practice for prevention, diagnosis, and management of venous thromboembolism in patients with coronavirus disease 2019 (COVID‐19) is unknown due to limited published data in this population.
45
Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)
Fionnuala Ní Áinle,Barry Kevane +1 more
TL;DR: Gender-specific risks, including VTE recurrence risk following hormone- and pregnancy-associated VTE events, are described, as well as how the competing impacts of Vte recurrence and bleeding have shaped international guideline recommendations.
38
Elevated venous thromboembolism risk in preeclampsia: molecular mechanisms and clinical impact
TL;DR: Evidence for the role of neutrophil extracellular traps and cell-free DNA in the pathogenesis of VTE has emerged and some evidence exists to suggest that this may be of relevance in preeclampsia.
33